glp-1 from china has approved Pfizer's treatment ​Xianweiying for long-term weight management in overweight or ‌obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market China Approval of Ecnoglutide Expands

These medications are game-changers in the treatment of type 2 diabetes

Channel segmentation is split between prescription (Rx) and over-the-counter (OTC) formats

The most frequently reported side effects of semaglutide are gastrointestinal in nature

muciniphila has been shown to be reduced in obese and T2D mice and that administration of A

If we were just to get a fraction [of our potential member base] to engage in the way that we do things differently with GLP-1s its an insane opportunity for the company, said Cliff Edberg, senior director of Miora

Report any suspected side effects to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)